All In MedTech

FDA Clearance Tracker · P830055-S265

LCS Total Knee System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: May 10, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

May 10, 2021

Approved

Time to decision

24 days

Received Apr 16, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P830055-S265
Device name
LCS Total Knee System
Applicant
Depuy, Inc.
Applicant location
Warsaw, IN
Received
Apr 16, 2021
Decided
May 10, 2021
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P830055

Device type

Device class
Class III

Every decision under product code NJL

FDA's approval statement

As written in FDA's record.

Approval for a manufacturing site located at Johnson & Johnson Medical (DePuy Suzhou) Ltd., No. 299, Changyang Street, Suzhou Industrial Park, Suzhou Jiangsu, China, to manufacture ATTUNE CR and ATTUNE PS Femoral Components of the LCS Total Knee System.

Source documents

Other decisions for Depuy, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.